US OptionsDetailed Quotes
OTLK250516C1000
- 0.00
- 0.000.00%
15min DelayClose May 6 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover0.00%IV-30.07%PremiumMay 16, 2025Expiry Date0.43Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.79Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Outlook Therapeutics Stock Discussion
Major FDA Milestone: Novel Wet AMD Drug Gets Review Date, Could Be First-of-its-Kind Approval
Just
Outlook Therapeutics® Re-Submits Biologics License Application for Ons-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration! Expected decision within 6 Months
Can Outlook's Eye Treatment Win FDA Approval Despite Missing Primary Endpoint?
The Q1 FY2025 results reveal a complex financial situation requiring careful analysis. While the reported $17.4M net income appears positive, the adjusted net loss of $21.6M reflects significant operational costs and excludes non-cash gains from warrant and convertible note valuations. This 16.7% increase in adjusted net loss compared to the previous year ($10.1M) indicates growing operational expenses as the company approaches commercialization....
Outlook Reports Stunning Earnings Turnaround: From $11.2M Loss to $17.4M Profit as European Launch Approaches
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY,...
Major Clinical Trial Success: Revolutionary Eye Treatment Shows Promise in NORSE EIGHT Study
No comment yet